Vaccine-Induced Myocarditis in Two Intern Doctors in the Same Night Shift

Area of Science:

• Cardiology
• Immunology
• Public Health

Background:

• The COVID-19 pandemic necessitated rapid vaccine development, with BNT162b2 emerging as a key preventative measure.
• While generally safe, vaccine side effects like myocarditis, though rare, require monitoring and reporting.
• Myocarditis, an inflammation of the heart muscle, is a known potential adverse event associated with certain vaccines.

Observation:

• This case report details two cases of vaccine-induced myocarditis in young, healthy male medical students.
• Both individuals received the first dose of the BNT162b2 vaccine shortly before symptom onset.
• The patients presented with symptoms consistent with myocarditis following vaccination.

Findings:

• The cases demonstrate that vaccine-induced myocarditis can occur even after the initial dose of the BNT162b2 vaccine.
• Both medical students experienced a favorable prognosis and good recovery after the diagnosis.
• No prior medical history was reported in either patient, highlighting the potential for occurrence in healthy individuals.

Implications:

• These findings underscore the importance of surveillance for myocarditis following COVID-19 vaccination, particularly after the first dose.
• Despite rare side effects, COVID-19 vaccination remains the most effective strategy for pandemic prevention due to lower morbidity compared to the disease itself.
• Healthcare providers should be aware of this potential adverse event in young males post-vaccination.